Name of opportunity: 👀
TC BioPharm Ltd
A penny stock to watch 💵
TC BioPharm is a penny stock and is classified as a growth stock. A penny stock is typically defined as a small company’s stock that has a price value of $5 or less. A growth stock means the company tends to reinvest profits to grow.
TC BioPharm is said to have a solid book value per share and is generating a healthy cash flow. Analysts are currently calling this stock a buy.
How hot is this investment opportunity? 🔥🔥🔥
Analysts predict the price of TC BioPharm Ltd might increase from $0.65 to $3.00 in the next 12 months. If you invested $1000, you might profit $3615.38.
One reason why TC BioPharm Ltd has seen a surge in price might be because of the company's recent announcement of its special stock dividend. A special dividend of 0.25 American Depositary Shares for every 1 ADS held by shareholders has been approved by the company’s board of directors.
The new dividend is expected to be officially declared on December 30th, which means that shareholders that hold the company’s stock receive the divided payment on the 2nd of January 2025.
This announcement comes just a week after TC BioPharm and CareDx declared a partnership to perform pharmacokinetic analysis in the ACHIEVE clinical trial. This is another positive sentiment for TC BioPharm, and might be why the company has attracted investors.
Research and product development 🧬
TC BioPharm Ltd is a clinical-stage cell therapy biopharmaceutical company based in Scotland, United Kingdom. The company develops advanced allogeneic CAR-T Cell therapy products for cancer treatment.
Which neme?: 🔍
‘Top Gainers Today’, ‘Stocks On The Move’.
Download Nemo Money to check out TC BioPharm Ltd. New users can grab our registration bonus up to a maximum of $50. Top up your account and get 50% extra from us. Terms and conditions apply.
